The Cancer Genome Atlas (TCGA) dataset analysis revealed that CD276 mRNA levels are significantly higher in TNBC (and other breast cancer) tissues compared to normal breast tissue (Fig. 1A). This evidence concerns the gene CD276 and breast carcinoma.